Community nephrologist · Royal Marsden · United Kingdom (GB) · Nephrology
Data minimisation
Cadence target for Tier 1: 4 per year (assumption)
1 of 2 expected engagements
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 16 Apr 2026 | Scientific exchange | Phone | Dr. Anna Becker | Nephrada | Patient-reported outcomesProteinuria as surrogate endpoint | 1 | — | Reviewed | ENG-0160 |
| 13 Mar 2026 | Congress meeting | Virtual | Dr. Anna Becker | Nephrada | eGFR slope interpretation | 0 | — | Reviewed | ENG-0153 |
| 03 Feb 2026 | Advisory board | In person | Dr. Anna Becker | Nephrada | Treatment burden and fatigue | 1 | — | Reviewed | ENG-0150 |
16 Apr 2026
Patient-reported outcomes, Proteinuria as surrogate endpoint
13 Mar 2026
eGFR slope interpretation
03 Feb 2026
Treatment burden and fatigue
Royal Marsden
Thoracic medical oncologist
Radiation oncologist
Pathologist
Community nephrologist
Renal pathologist
Headache specialist
Primary care physician